Charles Russell Speechlys advises Vapotherm on the acquisition of Solus Medical
Charles Russell Speechlys has advised Vapotherm, Inc., a global medical technology company, on the acquisition of its former UK distributor Solus Medical Limited. Solus is based in Scotland and the acquisition provides Vapotherm with a UK-based direct sales organisation.
Vapotherm, Inc. (NYSE: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA, which develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 1.7 million patients have been treated with Vapotherm’s proprietary Hi-VNI Technology, which delivers non-invasive ventilatory support for spontaneously breathing patients and is a front-line tool for relieving respiratory distress, including hypercapnia, hypoxemia, and dyspnea.
Anthony Ten Haagen, VP Legal Affairs & Compliance at Vapotherm, commented “Daniel Rosenberg, Jonathan Steele, and the entire Charles Russell Speechlys team were invaluable in guiding us through this acquisition quickly and efficiently, and we look forward to continuing to work with them through the integration effort”.
Daniel Rosenberg, Corporate Partner at Charles Russell Speechlys, said “we were delighted to work with Vapotherm on this first acquisition following its IPO on NYSE in last November and we look forward to working with the Vapotherm team as they continue to expand internationally”.
The Charles Russell Speechlys team was led by Daniel Rosenberg and included Jonathan Steele and Tertius Alberts (Corporate), Caroline Young (Commercial/Healthcare) and Becky Lawton and Josie Macleod (Employment). The team worked with Brodies on Scottish law issues.
Marcus Stuttard will provide his unique insight and a "state of the nation" market update.
Charles Russell Speechlys advises Topland Group on two key transactions
Topland Group is one of the largest multi-billion pound, privately owned investment groups.
Yahoo and Food Business Africa cover the firm's involvement in Oba Pack's investment in the Babator Farming Company
Oba Pack Company Limited, a Ghanaian-owned agribusiness, purchased the Babator Farming Company Limited (BFC) on 31 December 2021.
Becky Lawton and Francesca Charlton write for P3 Pharmacy on employment issues for pharmacies in light of the Omicron variant
What can owners and managers do if staff refuse to comply with latest restrictions?
Le Monde du Droit and Fin Year cover the firm's involvement in Resilience's acquisition of Betterise
The Paris office has advised Resilience on their acquisition of Betterise.
Melania Constable and Georgina O'Sullivan write for P3 Pharmacy on the easing of Covid winding up restrictions
Regulations mean that a creditor can once again rely on an unpaid statutory demand to apply to the court for a winding-up petition.
Diversity and Inclusion: Clear transparency?
This article focuses on the published its Consultation Paper on diversity and inclusion on company boards and executive committees in July.
Listing Rules changes are in...exciting times for founders and fast-growing companies
Charles Russell Speechlys advises FairXchange on investment from United Fintech
FairXchange was founded in 2016, to bring clarity and transparency to execution performance through the provision of independent data.
ESG - do your priorities need to change with a changing landscape?
This article lists the forthcoming legislation and other initiatives which impact on public and quoted companies.
Mandatory climate-related disclosures coming soon
On 28 October 2021, the government published its response to its consultation on mandatory climate-related disclosures.
Charles Russell Speechlys advises Acora on the acquisition of M9 Holdings
The acquisition of M9 Holdings marks the latest stage in Acora’s growth journey.
Reform of the UK Prospectus Regime
This article focuses on three aspects of the consultation: Quality and Duplication, Widening participation in public offers, Agility
Piers Master and James Broadhurst write for eprivateclient on the goals of a family office
What are the goals, priorities or concerns often raised by families?
Rebecca Burford quoted by Citywealth on family offices’ ESG considerations for their private market investments
Family offices are increasingly deploying a growing portion of their assets to the private markets.
The Surrey Chambers of Commerce report on the Dental team’s involvement in Dentex’s acquisition of its 100th dental practice
The Dental team in Guildford has advised Dentex on the acquisition of Courtyard Dental Practice based in Saffron Walden in Essex.
Charles Russell Speechlys advises Dentex on the acquisition of Courtyard Dental Practice
Dentex is a fast-growing dental group focussed on developing its practices and optimising how dental practices operate.
Charles Russell Speechlys advises Puma Private Equity on their investment into Everpress
Puma Private Equity offers a wide range of award-winning investments that help to support investors.
Helen Coward and Cara Whiffin write for Property Week on how the residential property developer tax will affect the retirement living sector
The new residential property developer tax (RPDT) is being introduced from 1 April 2022.
International Adviser report on the firm's appointment of David Collins as Divisional Managing Partner for Business Advisory & Transaction Services
David Collins has been named as Divisional Managing Partner.